Ascidian chief scientific officer Robert Bell (L) overlooks research in the company's lab in Boston (courtesy Ascidian) Lilly strikes Ascidian deal worth up to $1.9B for RNA editing in kidney diseases Last month, Ascidian Therapeutics presented the first data suggesting a new way to fix broken genes may be safe in people
Summary Keywords biomarkers, Caribbean region, diagnosis, disease susceptibility, Latin America, prognosis, prostatic neoplasms, therapeutics Citation Prada NJ, Mendivelso-Gonzlez D, Yepes S, Corredor C, Parra-Medina R, Varela R and Serrano ML (2026) Research on potential biomarkers of prostate cancer in Latin America and the Caribbean: a scoping review
The impaired tumour growth induced by GGsTop treatment was rescued by supplementation with a cell-permeable source of cysteine (NAC) (Fig
Gene therapy, which involves inserting genes into patients cells rather than using drugs to treat RA, is a treatment strategy that remains in its early stages of development
This is a cash-pay service